Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
17
HUMA Quote, Financials, Valuation and Earnings
Last price:
$1.08
Seasonality move
:
-6.75%
Day range:
$1.06 - $1.15
52-week range:
$1.04 - $5.66
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
98.39x
P/B ratio:
54.99x
Volume:
2.5M
Avg. volume:
4.8M
1-year change:
-76.05%
Market cap:
$202.3M
Revenue:
--
EPS (TTM):
-$0.24
Earnings Data
Next earnings date for HUMA
Mar 27
2026
Most recent earnings per share
-$0.11
Beat by $0.04
(Nov 12/2025)
Consensus Estimate
-$0.15
(Nov 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
HUMA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/27/2026 | Q4 | $1.3M | -- | -- | -$0.14 | -- |
| 11/12/2025 | Q3 | $922.8K | $753K | -$0.11 | -$0.15 | $0.04 |
| 08/11/2025 | Q2 | $1M | $301K | -$0.24 | -$0.18 | -$0.07 |
| 05/15/2025 | Q1 | $764.8K | $517K | $0.28 | -$0.21 | $0.49 |
| 03/28/2025 | Q4 | -- | -- | -$0.16 | -$0.26 | $0.09 |
| 11/08/2024 | Q3 | -- | -- | -$0.33 | -$0.25 | -$0.08 |
| 08/13/2024 | Q2 | -- | -- | -$0.48 | -$0.24 | -$0.24 |
| 05/10/2024 | Q1 | -- | -- | -$0.29 | -$0.23 | -$0.06 |
| 03/22/2024 | Q4 | $50K | -- | -$0.24 | -$0.23 | -$0.02 |
| 11/09/2023 | Q3 | $66.7K | -- | -$0.25 | -$0.25 | $0.00 |
| 08/14/2023 | Q2 | -- | -- | -$0.22 | -- | -- |
| 05/12/2023 | Q1 | -- | -- | -$0.36 | -- | -- |
| 03/24/2023 | Q4 | -- | -- | -$0.04 | -- | -- |
| 11/10/2022 | Q3 | -- | $31K | -$0.25 | -- | -- |
| 08/12/2022 | Q2 | -- | $1.3M | $0.35 | -- | -- |
| 05/13/2022 | Q1 | -- | $233K | -$0.19 | -- | -- |
| 03/29/2022 | Q4 | -- | -- | $0.41 | -- | -- |
| 11/12/2021 | Q3 | -- | $241K | -$0.72 | -- | -- |
| 09/22/2021 | Q2 | -- | $690K | -$2.89 | -- | -- |
| 03/31/2021 | Q1 | -- | $155K | -$3.46 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$2.78 | -- | -- |
| 09/30/2020 | Q3 | -- | $914K | -$0.00 | -- | -- |
Humacyte, Inc. Earnings Questions
-
How Much did Humacyte, Inc. Generate in Revenue Last Quarter?
Humacyte, Inc. reported $753K worth of top line sales in its most recent quarter.
-
Did Humacyte, Inc. Beat Earnings Last Quarter?
Humacyte, Inc. announced earnings per share of -$0.11 which represents a beat of analyst forecast a -$0.15 per share.
-
Is Humacyte, Inc. Profitable?
Humacyte, Inc. reported -$1.4M that represents -$0.01 per share over the last quarter.
-
What is the Analyst Consensus for Humacyte, Inc. EPS Next Year?
Humacyte, Inc.'s earnings are forecast to decrease from -$1.26 per share to -$1.27 per share next year representing a decrease of -69.41%.
-
When is Humacyte, Inc.'s Earnings Date?
Humacyte, Inc.'s next earnings date is March 27, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
